ResMed: Michael Farrell proposes $1.13M share sale

The notice also records a cash-paid stock-option exercise and three sales reported for the preceding three months.

Rhea-AI Filing Summary

ResMed Inc. is named as issuer in a notice reporting Michael Farrell’s proposed sale of 4,991 common shares, with an aggregate market value of $1,129,637.70. The sale is listed through Fidelity Brokerage Services LLC for approximately October 7, 2026, on NYSE. A separate securities detail lists a cash-paid stock option exercise of 4,991 shares on October 7, 2026. The past-three-months table lists three earlier sales of 4,991 shares each.

Key Figures

Proposed shares for sale: 4,991 shares Aggregate market value: $1,129,637.70 Shares sold: 4,991 shares +5 more

8 metrics

Proposed shares for sale 4,991 shares ResMed common shares

Aggregate market value $1,129,637.70 Proposed sale

Shares sold 4,991 shares July 7, 2026

Gross proceeds $1,090,770.57 Sale on July 7, 2026

Shares sold 4,991 shares August 7, 2026

Gross proceeds $1,026,596.29 Sale on August 7, 2026

Shares sold 4,991 shares September 8, 2026

Gross proceeds $1,110,190.55 Sale on September 8, 2026

Key Terms

Rule 144, Stock Option Exercise, Aggregate market value

3 terms

Rule 144 regulatory

"definition of “person” in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RMD shares did Michael Farrell report for sale?

Michael Farrell’s notice reports a proposed sale of 4,991 ResMed common shares, with an aggregate market value of $1,129,637.70 and an approximate sale date of October 7, 2026. Fidelity Brokerage Services LLC is listed as the broker, and NYSE as the exchange.

What recent RMD sales did Michael Farrell report?

The past-three-months table lists sales of 4,991 shares on July 7, 2026, for $1,090,770.57; 4,991 shares on August 7, 2026, for $1,026,596.29; and 4,991 shares on September 8, 2026, for $1,110,190.55.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/07/2026 - 04:23 PM Accepted by SEC EDGAR 10/07/2026 - 04:22 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001485164
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RESMED INC
SEC File Number	001-15317
Address of Issuer	9001 SPECTRUM CENTER BLVD. SAN DIEGO CALIFORNIA 92123
Phone	8587462400
Name of Person for Whose Account the Securities are To Be Sold	Farrell Michael J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4991	1129637.70	144252306	10/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/07/2026	Stock Option Exercise	Issuer			4991	10/07/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	07/07/2026	4991	1090770.57
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	08/07/2026	4991	1026596.29
Michael Farrell 9001 Spectrum Center Blvd., San Diego CA 92123	Common	09/08/2026	4991	1110190.55

144: Remarks and Signature

Remarks
Date of Notice	10/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/31/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Farrell.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)